Blood Brain Barrier Flashcards
The BBB is formed by ??? junctions between endothelial cells that line capillaries. these junctions are induced by ??? and prevent passive transfer from the blood into the brain
tight junctions
astrocytes
Lipid-soluble substances cross endothelial cells through membranes via ??? diffusion
transmembrane diffusion
a substance that is too lipid soluble can be sequestered by the capillary bed and not reach the cells behind the BBB. WHY?
a drug taken up by the membranes that form the BBB must partition into the aqueous environment of the brain’s interstitial fluid to exert an effect
BBB has specialised transporters to allow transport of essential water soluble substances such as neurotransmitter precursors and glucose - this is termed ??? transport
carrier mediated transport
capillary endothelial cells produce carrier molecules that transport selected essential substances such as ???
glucose, Large amino acids e.g. phenylalanine and neurotransmitter precursors, L-dopa,
TRUE or FALSE: carrier proteins are synthesised by capillary endothelial cells and use active transport to transport selected molecules across BBB. Therefore, capillary endothelial cells DON’T contain loads of mitochondria
FALSE THEY DO CONTAIN LOADS
pGlycoprotein (P-gp) is also known as multidrug resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1) and is an ??? transporter
efflux
what is an efflux transporter that is highly expressed in the vessel walls of the brain capillaries because of capacity to extrude a large range of compounds from the brain, hence considered to be greatly important for protecting brain from accumulation of potentially toxic substances.
pGlycoprotein AKA multidrug resistance protein 1
an efflux transporter is a transporter that moves things ??? cells
out of
??? inhibitors are of great interest in pharmacology research as potential avenue to block the efflux of therapeutic agents that are needed to reach the brain.
p-glycoprotein
in which disease of the brain is there evidence to suggest that p-glycoprotein is reduced in the brain, resulting in reduced ability to clear amyloid-beta plaques
Alzheimer’s
In Amytrophic Lateral Sclerosis (ALS) there is evidence of over-expression of ??? transporters = therapeutic failure of ALS drugs
p-glycoprotein
Individuals with the disorder, phenylketonuria (PKU), have mutations in the ??? hydroxylase gene.
phenylalanine
??? leads to hyper-phenylalaninemia (i.e. too much phenylalanine in the blood)
Phenylketonuria